FDA Approves Novel Chronic Hepatitis B Treatment

The U.S. Food and Drug Administration has granted approval for a new, first-of-its-kind treatment for chronic Hepatitis B. This significant development offers a new therapeutic option for patients battling the infection and includes a companion diagnostic device to guide patient selection and treatment monitoring. This advancement could improve outcomes for those with chronic Hepatitis B.